SG10201908277TA - Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) - Google Patents
Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas)Info
- Publication number
- SG10201908277TA SG10201908277TA SG10201908277TA SG10201908277TA SG 10201908277T A SG10201908277T A SG 10201908277TA SG 10201908277T A SG10201908277T A SG 10201908277TA SG 10201908277T A SG10201908277T A SG 10201908277TA
- Authority
- SG
- Singapore
- Prior art keywords
- breast cancer
- mirnas
- risk
- detecting
- determining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Biomedical Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Plant Pathology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201501781W | 2015-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201908277TA true SG10201908277TA (en) | 2019-10-30 |
Family
ID=56880404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201908277T SG10201908277TA (en) | 2015-03-09 | 2016-03-09 | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) |
| SG11201707325RA SG11201707325RA (en) | 2015-03-09 | 2016-03-09 | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707325RA SG11201707325RA (en) | 2015-03-09 | 2016-03-09 | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180230544A1 (fr) |
| EP (2) | EP3916106A1 (fr) |
| CN (3) | CN116064800A (fr) |
| ES (1) | ES2882104T3 (fr) |
| HK (1) | HK1249555A1 (fr) |
| SG (2) | SG10201908277TA (fr) |
| WO (1) | WO2016144265A1 (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729751B (zh) * | 2015-11-20 | 2020-03-06 | 中国医学科学院肿瘤医院 | 一种microRNA分子用于检测和治疗乳腺癌的用途 |
| WO2018056432A1 (fr) * | 2016-09-26 | 2018-03-29 | 東レ株式会社 | Procédé de détection d'hémolyse dans un échantillon sanguin et puce de détection d'hémolyse |
| US11976330B2 (en) * | 2017-04-06 | 2024-05-07 | The University Of Vermont And State Agricultural College | MiRNA signature expression in cancer |
| EP3701050B1 (fr) * | 2017-10-24 | 2024-03-06 | Université Paris Cité | Diagnostic et/ou pronostic du cancer dépendant de her2 utilisant un ou plusieurs arnmi comme biomarqueur |
| CN107815492A (zh) * | 2017-12-08 | 2018-03-20 | 武汉科技大学 | 一种基于qpcr诊断乳腺癌的检测方法 |
| JP7298913B2 (ja) * | 2017-12-13 | 2023-06-27 | 国立大学法人広島大学 | 乳がんの検出を補助する方法 |
| GB201802404D0 (en) * | 2018-02-14 | 2018-03-28 | Univ Malta | Methods |
| CN108531586B (zh) * | 2018-03-19 | 2022-03-29 | 朱伟 | 一种与乳腺癌辅助诊断相关的位于X染色体上的循环miRNA标志物及其应用 |
| CN109337978B (zh) * | 2018-07-03 | 2023-12-01 | 华中科技大学同济医学院附属同济医院 | miRNA在制备高级浆液性上皮性卵巢癌化疗耐药性评价试剂盒中的应用 |
| CN108950003B (zh) * | 2018-09-10 | 2022-02-11 | 山东大学齐鲁医院 | 一种用于诊断乳腺癌的miRNA标志物及其miRNA的应用 |
| CN109182524A (zh) * | 2018-09-29 | 2019-01-11 | 江苏医诺万细胞诊疗有限公司 | 一种辅助诊断宫颈癌及其癌前病变的miRNA组合标志物及其应用 |
| CN109609630B (zh) * | 2018-12-03 | 2023-01-13 | 哈尔滨医科大学 | 用于早期胃癌诊断的分子标志物及其应用 |
| CN109295233A (zh) * | 2018-12-10 | 2019-02-01 | 复旦大学附属中山医院 | 一种联合检测miRNA诊断结直肠癌的试剂盒 |
| CN109609633B (zh) * | 2018-12-24 | 2022-02-11 | 朱伟 | 一种与乳腺癌辅助诊断相关的血清miRNA标志物及其应用 |
| CN109593851B (zh) * | 2018-12-24 | 2022-02-11 | 朱伟 | 一种与乳腺癌辅助诊断相关的血浆miRNA标志物及其应用 |
| CN110029169A (zh) * | 2019-04-30 | 2019-07-19 | 觅瑞实验室私人有限公司 | 一种检测胃癌的miRNA标志物组合及试剂盒 |
| EP3772543B1 (fr) * | 2019-08-09 | 2023-09-27 | Albert-Ludwigs-Universität Freiburg | Procédé de diagnostic du cancer du sein |
| CN112516155A (zh) * | 2019-09-18 | 2021-03-19 | 四川大学华西医院 | 一种三阴乳腺癌的基因治疗制剂 |
| CN110804659B (zh) * | 2019-10-23 | 2023-02-03 | 华南农业大学 | 一种血清外泌体ssc-miR-92b-3p作为母猪早期妊娠诊断分子标志物的应用 |
| CN110787181B (zh) * | 2019-12-10 | 2022-11-15 | 合肥市第二人民医院 | 一组miRNA及其在生物靶向治疗乳腺癌中的应用 |
| CN112980947A (zh) * | 2019-12-12 | 2021-06-18 | 中国科学院大连化学物理研究所 | 检测与肺癌诊疗相关的外周血循环microRNA的引物及试剂盒 |
| CN111653315A (zh) * | 2020-05-29 | 2020-09-11 | 杭州广科安德生物科技有限公司 | 构建体外检测乳腺癌的数学模型的方法及其应用 |
| CN111518914B (zh) * | 2020-06-09 | 2021-12-24 | 上海圣梓茂生物科技有限公司 | 用于检测乳腺癌的miRNA标记物组合、试剂盒和方法 |
| WO2022051141A1 (fr) * | 2020-09-03 | 2022-03-10 | The Trustees Of Indiana University | Méthodes pour le dépistage précoce du cancer du sein |
| CN113151477B (zh) * | 2021-05-08 | 2022-04-15 | 武汉大学中南医院 | 用于检测肠癌的miRNA标记物及其应用 |
| CN113215256A (zh) * | 2021-05-10 | 2021-08-06 | 深圳市展行生物有限公司 | 一种评估乳腺癌风险的方法及其使用的miRNA组合 |
| CN118043484A (zh) * | 2021-08-02 | 2024-05-14 | 新加坡国立大学 | 用于乳腺癌早期检测的循环微rna组及其方法 |
| CN114107501B (zh) * | 2021-11-26 | 2024-04-30 | 馥鼎(上海)生物医药有限公司 | 外周血循环miRNA在制备预防、诊断或预后评估乳腺癌的生物标记物中的用途 |
| WO2023170659A1 (fr) * | 2022-03-11 | 2023-09-14 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) | Diagnostic et traitement du cancer du sein |
| WO2024089689A1 (fr) * | 2022-10-25 | 2024-05-02 | Clonal Ltd | Méthodes de détection du cancer du sein |
| WO2024127723A1 (fr) * | 2022-12-16 | 2024-06-20 | Kabushiki Kaisha Toshiba | Procédé d'analyse, kit et dispositif de détection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101988061A (zh) * | 2009-07-30 | 2011-03-23 | 江苏命码生物科技有限公司 | 乳腺癌检测标记物及其检测方法、试剂盒和生物芯片 |
| WO2011094335A2 (fr) * | 2010-01-26 | 2011-08-04 | Yale University | Signatures de microarn prédictives de la réponse à une thérapie anti-her2 |
| CN101921760B (zh) * | 2010-09-08 | 2012-02-01 | 南京医科大学 | 一种与乳腺癌相关的血清/血浆miRNA标志物及其应用 |
| WO2013057567A1 (fr) * | 2011-10-19 | 2013-04-25 | Council Of Scientific And Industrial Research (C.S.I.R.) | Biomarqueurs servant à détecter des types, niveaux et stades du cancer du sein chez l'être humain |
| US10316367B2 (en) * | 2012-06-21 | 2019-06-11 | Ruprecht-Karls-Universität Heidelberg | Circulating miRNAs as markers for breast cancer |
| WO2014129975A1 (fr) * | 2013-02-20 | 2014-08-28 | Singapore Health Services Pte Ltd | Identification de signatures de microarn en circulation pour la détection du cancer du sein |
| US10086093B2 (en) * | 2013-02-28 | 2018-10-02 | The General Hospital Corporation | miRNA profiling compositions and methods of use |
| WO2014193309A1 (fr) * | 2013-05-30 | 2014-12-04 | Agency For Science, Technology And Research | Procédé de détermination de pronostic de cancer |
-
2016
- 2016-03-09 WO PCT/SG2016/050113 patent/WO2016144265A1/fr active Application Filing
- 2016-03-09 SG SG10201908277T patent/SG10201908277TA/en unknown
- 2016-03-09 CN CN202211111821.3A patent/CN116064800A/zh active Pending
- 2016-03-09 CN CN202211111823.2A patent/CN116064801A/zh active Pending
- 2016-03-09 EP EP21161797.2A patent/EP3916106A1/fr active Pending
- 2016-03-09 ES ES16762077T patent/ES2882104T3/es active Active
- 2016-03-09 EP EP16762077.2A patent/EP3268494B1/fr active Active
- 2016-03-09 SG SG11201707325RA patent/SG11201707325RA/en unknown
- 2016-03-09 CN CN201680014611.9A patent/CN107429295B/zh active Active
- 2016-03-09 US US15/557,457 patent/US20180230544A1/en active Pending
-
2018
- 2018-07-11 HK HK18108972.5A patent/HK1249555A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1249555A1 (zh) | 2018-11-02 |
| EP3268494A1 (fr) | 2018-01-17 |
| EP3268494A4 (fr) | 2018-11-07 |
| EP3916106A1 (fr) | 2021-12-01 |
| ES2882104T3 (es) | 2021-12-01 |
| CN116064801A (zh) | 2023-05-05 |
| CN107429295B (zh) | 2022-09-30 |
| EP3268494B1 (fr) | 2021-04-21 |
| CN116064800A (zh) | 2023-05-05 |
| US20180230544A1 (en) | 2018-08-16 |
| SG11201707325RA (en) | 2017-10-30 |
| CN107429295A (zh) | 2017-12-01 |
| WO2016144265A1 (fr) | 2016-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201908277TA (en) | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) | |
| EP3744859A3 (fr) | Biomarqueur à base de microarn utilisable en vue du diagnostic du cancer gastrique | |
| MX2023001945A (es) | Composiciones y metodos para el cribado de tumores solidos. | |
| MX2022012384A (es) | Composiciones y metodos para cribar mutaciones en el cancer de tiroides. | |
| MX2017010836A (es) | Panel biomarcador para la deteccion de cancer. | |
| TN2013000358A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
| MX341840B (es) | Biomarcadores de microarn indicativos de la enfermedad de alzheimer. | |
| IN2013CN01129A (fr) | ||
| TN2013000464A1 (en) | Biomarkers for hedgehog inhibitor therapy | |
| WO2013182912A3 (fr) | Méthode pour le diagnostic, le pronostic et le traitement d'une métastase du cancer du poumon | |
| WO2015172085A3 (fr) | Biomarqueurs utilisables pour évaluer la réponse aux inhibiteurs de la pi3k | |
| WO2013148147A8 (fr) | Analyse de la méthylation de l'adn à des fins diagnostiques, pronostiques et thérapeutiques des néoplasies des glandes surrénales | |
| EA201790549A1 (ru) | Предиктивные и прогностические биомаркеры, связанные с антиангиогенной терапией злокачественной опухоли | |
| MX2016004557A (es) | Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama. | |
| TR201909951T4 (tr) | Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem. | |
| WO2014057357A3 (fr) | Méthode pour le diagnostic, le pronostic et le traitement d'une métastase du cancer de la prostate | |
| WO2013025952A3 (fr) | Procédés et compositions pour le traitement et le diagnostic du cancer du sein | |
| WO2013106844A3 (fr) | Procédés et compositions pour le traitement et le diagnostic du cancer du pancréas | |
| WO2018136919A3 (fr) | Méthodes se rapportant au cancer du poumon | |
| WO2015095862A3 (fr) | Biomarqueurs de micro-arn pour le cancer de l'ovaire | |
| EP3495502A3 (fr) | Biomarqueurs pour la naissance prématurée | |
| MX2016012278A (es) | Deteccion temprana de preeclampsia. | |
| MX2017003832A (es) | Metodo para la prediccion de sensibilidad a un tratamiento con un inhibidor de egfr. | |
| ES2548299A1 (es) | Firma de microARN como indicador del riesgo de recurrencia temprana en pacientes con cáncer de mama | |
| IN2014DN08312A (fr) |